Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party
- Affiliations
-
- 1Department of Internal Medicine, Korea University School of Medicine, Seoul, Korea.
- 2Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- 3Department of Pathology, Kyungpook National University School of Medicine, Daegu, Korea.
- 4Department of Pathology, Konkuk University Medical Center, Seoul, Korea.
- 5Department of Laboratory Medicine, University of Ulsan College of Medicine, Seoul, Korea.
- 6Department of Pathology, Korea University School of Medicine, Seoul, Korea.
- 7Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
- 8Department of Pathology, Ajou University School of Medicine, Suwon, Korea.
- 9Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. csuh@amc.seoul.kr
Abstract
- In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.